Hepatitis C virus infection: Are there still specific problems with genotype 3?
Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey, Department of Hepato-gastroenterology A, Hospital Saint Eloi, CHRU, 34295 Montpellier, France
Claire Gondeau, Dominique Larrey, INSERM U1183, Institute of Regenerative Medicine and Biotherapy, University of Montpellier, 34295 Montpellier, France
Author contributions: Gondeau C conducted the review of existing research and drafted the manuscript; Pageaux GP and Larrey D edited the final version.
Supported by Agence Nationale de la Recherche sur le SIDA et les Hépatites Virales.
Conflict-of-interest statement: Gondeau C declare no conflict of interest; Pageaux GP and Larrey D have received fees for serving as speakers and advisory board members for BMS, Gilead, Merck, Janssen. Larrey D has received fees for serving as a speaker and advisory board member for Abbvie.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Claire Gondeau, PhD, INSERM U1183, Institute of Regenerative Medicine and Biotherapy, University of Montpellier, 34295 Montpellier, France. firstname.lastname@example.org
Telephone: +33-4-67330493 Fax: +33-4-67330459
Received: June 29, 2015
Peer-review started: July 3, 2015
First decision: July 20, 2015
Revised: August 7, 2015
Accepted: September 30, 2015
Article in press: September 30, 2015
Published online: November 14, 2015